Press ReleaseAIMHI_wpuser2024-08-29T11:16:30+00:00

Press Release

Press Release

You Are Invited! 2023 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship

AIMHI_wpuser2025-02-21T15:59:24+00:00September 21, 2023|Press Release|

AIM-HI CEO & Co-Founder Sujuan Ba Ph.D. Recognized for Global Advocate of Cancer Research and Collaboration at BIOHK2023

AIMHI_wpuser2025-02-21T15:59:24+00:00September 16, 2023|Press Release|

AIM-HI Accelerator Fund Welcomes New Leadership and Members to Its Board of Directors

AIMHI_wpuser2025-02-21T15:59:24+00:00September 6, 2023|Press Release|

National Cancer Institute (NCI) Director, Monica M. Bertagnolli, M.D., Selected as Recipient of the 2023 AIM-HI Beacon Award for Women Leaders in Oncology

AIMHI_wpuser2025-02-21T15:59:40+00:00August 16, 2023|Press Release|

2023 AIM-HI Women’s Venture Competition Announced Six Semi-Finalists

AIMHI_wpuser2025-02-21T15:59:40+00:00May 4, 2023|Press Release|

Nominate & Honor a Trailblazing Woman Leader in Oncology

AIMHI_wpuser2025-02-21T15:59:40+00:00April 3, 2023|Press Release|

Previous 345 Next

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Address:

5515 Security Lane, Suite 1105
Rockville, MD 20852

Email:

info@aim-hiaccelerator.org

Phone:

1-800-321-CURE (2873)

what we do

Copyright © AIM-HI 2025 All Rights Reserved

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Copyright © AIM-HI 2025 All Rights Reserved